|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Aug―25 |
Alantolactone: A Potential Multitarget Drug candidate for Prevention of SARS-CoV-2 Cell Entry |
Erum Zafar, Zainab Ahsan, Muhammad Faisal Maqbool, Aqsa Zaman, Sameena Gul, Amara Maryam, et al. (+3) Muhammad Khan, Hafiz Abdullah Shakir, Muhammad Irfan |
2 |
[GO] |
2023―Aug―25 |
Docking and Dynamics Study of Phytochemicals as Potent Inhibitors against SARS-CoV-2 Main Protease |
Palla Ramprasad, Arunkumar Babu, Suveena Sukumaran |
3 |
[GO] |
2022―Dec―30 |
Comparative In-Silico Molecular Docking of Silymarin for SARS-CoV-2 Receptor |
Michael Antony Samy Amutha Gnana Arasi, Sapthasri Ravichandran, Irudayam Iayaraman |
4 |
[GO] |
2022―Feb―02 |
In Silico Anti-Inflammation Prediction of Glycyrrhiza Extracts Against Covid-19 |
Mansoureh Nazari |
5 |
[GO] |
2022―Feb―02 |
Corrigendum to "Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2” [J Mol Docking. 2021;1(2):1-14] |
Israa Mohamed Shamkh, Dina Pratiwi, Hanaa S. Omar |
6 |
[GO] |
2022―Feb―02 |
In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins |
Israa Mohamed Shamkh, Dina Pratiwi, Hanaa S. Omar, Nour El-Houda A. Reyad |
7 |
[GO] |
2021―Jun―29 |
Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2 |
Israa Mohamed Shamkh, Dina Pratiwi |
8 |
[GO] |
2021―Jun―29 |
Molecular Docking Studies of Phytoconstituents Identified in Traditional Siddha Polyherbal Formulations Against Possible Targets of SARS-CoV-2 |
Logesh Kumar Selvaraj, Geethanjali Thayumanavan, Srikanth Jeyabalan, Sugin Lal Jabaris |
9 |
[GO] |
2021―Jun―29 |
A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking |
Achal Mishra, Radhika Waghela |